Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-12

Clinical Trial Update: Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia [Phase 3]

View source ↗

Summary

Phase III randomized trial comparing cyclophosphamide with or without antithymocyte globulin before bone marrow transplantation in patients with aplastic anemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antithymocyte Globulin (anti-thymocyte globulin)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Aplastic Anemia | Phase 3 | Status: COMPLETED